LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Acrivon Therapeutics (NASDAQ: ACRV)

Follow NASDAQ:ACRV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
08/21/2025
Sell
$1.32
19,905
$26K
2.13M
NASDAQ ACRV Acrivon Therapeutics
Peterson Katharine / officer: Chief Accounting Officer
08/14/2025
Sell
$1.39
99
$138
4,221
NASDAQ ACRV Acrivon Therapeutics
Miller Mary / officer: Chief Legal Officer
08/14/2025
Sell
$1.39
184
$256
35,581
NASDAQ ACRV Acrivon Therapeutics
Gamelin Erick / officer: Chief Development Officer
08/14/2025
Sell
$1.39
403
$560
15,686
NASDAQ ACRV Acrivon Therapeutics
Devroe Eric / officer: Chief Operating Officer
08/14/2025
Sell
$1.39
613
$852
65,921
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
08/14/2025
Sell
$1.39
59,766
$83K
2.15M
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
08/14/2025
Sell
$1.39
490
$681
315,196
NASDAQ ACRV Acrivon Therapeutics
Levy Adam D. / officer: Chief Financial Officer
08/01/2025
Sell
$1.26
1,164
$1K
12,151
NASDAQ ACRV Acrivon Therapeutics
Miller Mary / officer: Chief Legal Officer
07/17/2025
Sell
$1.32
558
$737
35,765

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous